Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study

Background: Current practices for assessing response to anti-interleukin 5/R treatment in severe asthma patients are heterogeneous. The objective of this study was to achieve an expert consensus defining failure criteria for anti-interleukin 5/R treatment in severe asthma patients. Methods: Experts...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Laura Mattei, Carey M. Suehs, Khuder Alagha, Arnaud Bourdin, Christophe Brousse, Jeremy Charriot, Gilles Devouassoux, Stephanie Fry, Laurent Guilleminault, Marion Gouitaa, Camille Taille, Pascal Chanez, Laurie Pahus
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2021-10-01
Colecção:	Therapeutic Advances in Respiratory Disease
Acesso em linha:	https://doi.org/10.1177/17534666211049735
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!